Regulation of transcription factor Nrf2 (NF-E2-related factor 2) involves redox-sensitive proteasomal degradation via the E3 ubiquitin ligase Keap1/Cul3. However, Nrf2 is controlled by other mechanisms that have not yet been elucidated. We now show that Glycogen Synthase Kinase-3 (GSK-3) phosphorylates a group of Ser residues in the Neh6 domain of mouse Nrf2 that overlaps with an SCF/-TrCP destruction motif (DSGIS, residues 334-338) and promotes its degradation in a Keap1-independent manner. Nrf2 was stabilized by GSK-3 inhibitors in Keap1-null mouse embryo fibroblasts. Similarly, an Nrf2 ETGE mutant, which cannot be degraded via Keap1, accumulated when GSK-3 activity was blocked. Phosphorylation of a Ser cluster in the Neh6 domain of Nrf2 stimulated its degradation because a mutant Nrf2
INTRODUCTION
A disadvantage of aerobic life is the constant generation of potentially damaging reactive oxygen species (ROS). The intracellular levels of such species need to be tightly controlled in order to avoid oxidative stress.
Transcription factor Nrf2 (NF-E2-related factor 2) plays a critical role in redox homeostasis as it increases the expression of many antioxidant and drugmetabolizing genes, including heme oxygenase-1 (HO-1), NADPH:quinone oxidoreductase-1, glutathione S-transferases, glutamate-cysteine ligase, and glutathione peroxidases, in response to oxidative and electrophile stressors (13) . These genes all contain a common promoter enhancer called the antioxidant response element (ARE), and are transactivated by Nrf2. Because ROS play a role as intracellular signalling molecules for many physiological processes, Nrf2 can make an impact on numerous cell functions, ranging from differentiation and development to proliferation and inflammation. Therefore, Nrf2 activity influences neurodegenerative disease, cardiovascular disease and cancer (3, 4, 14, 16, 17, 50, 54) .
Whilst increased Nrf2 transcriptional activity enhances cellular antioxidant defences and increases the capacity to detoxify drugs, it may also lead to unwanted side effects. For instance, in tumours, high levels of Nrf2 activity have been correlated with poor prognosis (42) . Indeed, high Nrf2 activity has not been favoured during evolution (25, 26) , but its levels are restricted via both redox-dependent and redox-independent pathways in normal healthy cells (30) .
In normal cells, Keap1 (Kelch-like ECH-associated protein 1), an E3 ubiquitin ligase substrate adaptor, regulates the level of Nrf2 protein in a redoxdependent fashion (5, 20, 52) . The interaction between Nrf2 and Keap1 occurs via a 'two-site tethering' process, otherwise called the 'hinge and latch' mechanism. In this model, two motifs, a high-affinity ETGE motif and a lowaffinity DLG motif, within the N-terminal Neh2 domain of Nrf2 each interact with a separate Kelch-repeat domain present in the Keap1 homodimer (41) . Both the ETGE motif and the DLG motif are required for the transcription factor to be repressed by Keap1 (29) . In addition to its interaction with Nrf2, Keap1 also binds Cullin-3 (Cul3), which forms a core E3 ubiquitin ligase complex through an association with Ring-box1 protein (Rbx1, also called Roc1) (5, 10, 20, 52) .
The Keap1-Cul3-Rbx1 complex is able to ubiquitinate Nrf2 and target it for proteasomal degradation only under normal redox conditions, and upon exposure to oxidants or electrophiles, Cys-151, Cys-273 and Cys-288 in Keap1 become modified, leading to disturbance of the interaction between Nrf2 and Keap1 (8, 21, 50, 51) . Failure of Nrf2 to dock simultaneously onto both Kelchrepeat domains enables it to escape ubiquitination by Cul3-Rbx1 (21, 33, 48, 51) . Thus, stress-related modification of Keap1 results in Nrf2 stabilization, accumulation of the transcription factor in the nucleus, and up-regulation of ARE-driven genes. Perturbation of the Nrf2-Keap1 complex by oxidants and electrophiles is considered the principal mechanism by which Nrf2 accumulates and induces the ARE-gene battery. However, other regulatory mechanisms must exist in order to explain: 1) how Nrf2 contributes to the basal expression of certain ARE-driven genes under normal homeostatic conditions; 2) how Nrf2 activity returns to its low basal levels after the intracellular redox balance has been restored; 3) how Nrf2 activity is limited during oxidative and electrophile stress.
Conventional cell signalling studies have suggested that Nrf2 might be regulated by protein phosphorylation (2, 6, 15, 18, 37, 45) . Previously, we have presented data suggesting that GSK-3β influences the nuclear exclusion and inactivation of Nrf2 (38) (39) (40) . However, the mechanistic connection between GSK-3 and Nrf2 remains largely unexplored. A number of studies have demonstrated that GSK-3 directs the ubiquitination and proteasomal degradation of various transcription factors, and other proteins, by SCF/-TrCP; these include Snail (55) , -catenin (1, 22, 35) , Gli2 and Gli3 (34, 49) , Xom (56) , Cdc 25a (19) , FGD1 and 3 (11, 12) , Mcl-1 (7), securin (24) , prolactin receptor (47) and the phosphatase PHLPP1 (23) . In these instances, GSK-3 phosphorylates a cluster of Ser/Thr residues in target proteins, which are then recognized by SCF/-TrCP. In turn, the complex formed by SCF/-TrCP binds the Cullin-1 (Cul1) scaffold protein to form a complete E3 ligase by association with a linker protein called Skp1 and with Rbx1. Therefore, -TrCP is an adapter protein that contains a Skp1-binding site called F-box and a WD recognition domain for phosphorylated substrates in the consensus motif DpSGX (1) (2) (3) (4) pS (9, 43) .
To date, the existence of a phosphodegron in Nrf2 has not been explored. In the present paper, we report that Nrf2 is destabilized as a consequence of its phosphorylation by GSK-3 and subsequent ubiquitination by SCF/-TrCP. This pathway represents an alternative mechanism to the Keap1-dependent degradation of Nrf2 and provides a means by which this transcription factor can be regulated in a redox-independent manner.
MATERIALS AND METHODS
Cell Culture and reagents. Human embryonic kidney (HEK) 293T cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 80 mg/ml gentamycin. Mouse embryo fibroblasts (MEFs) from Keap1-knockout mice and wild-type littermates (kindly provided by Dr. Ken Itoh, Center for Advanced Medical Research, Hirosaki University Graduate School of Medicine, Japan) were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 0.5 U/ml penicillin and 0,5 g/ml streptomycin. Transient transfection of HEK293T cells was performed with calcium phosphate, using reagents from Sigma-Aldrich (Madrid, Spain). SB216763 and MG132 were from Sigma-Aldrich (Madrid, Spain). Cycloheximide (CHX) was purchased from Boehringer Mannheim (Germany).
Plasmids.
Expression vectors pcDNA3.1/V5HisB-mNrf2
, pHis-Ub and pET-mNrf2 have been described previously (30 In vitro kinase assays. In vitro phosphorylation was performed using as substrate bacterially expressed His-tagged Nrf2, isolated using the ProBond g/ml leupeptin). The cell lysates were diluted 10-fold with IP buffer (Tris-HCl, pH 7.5, 20 mM; NaCl, 137 mM; NaF, 20 mM; sodium pyrophosphate, 1 mM; Na 3 VO 4 , 1 mM; Nonidet P-40, 1%; glycerol, 10%; phenyl methyl sulphonyl fluoride, 1 mM; and leupeptin, 1 g/ml) and sonicated (3× for 30 s each).
Thereafter, the soluble portion of the lysates was prepared by centrifugation at 10,000 x g for 5 min at 4°C and retained for analysis. For immunoprecipitation, cell lysates were incubated with 3 μl of anti-V5 at 4°C with continuous rotation.
After 2 h, a 20-μl slurry of Protein G-Sepharose was added, and incubation was continued for an additional 1 h. Immunocomplexes were pelleted by centrifugation, washed three times in IP buffer, and resuspended in 40 μl of Laemmli sample buffer containing 1% β-mercaptoethanol. The samples were boiled, subjected to electrophoresis and transferred to Immobilon-P membranes.
After autoradiography, the blot was incubated with anti-V5 antibody to normalize the amount of Nrf2 protein per lane.
Image analyses and statistics. Different band intensities (density arbitrary units), corresponding to immunoblot detection of protein samples, were quantified using the MCID software (MCID, Cambridge, UK). Student's t test was used to assess differences between groups; a p value < 0.05 was 
RESULTS
GSK-3modulates Nrf2 protein levels. We first measured the levels of Nrf2 protein in HEK293T cells that had been treated with the two prototypic Nrf2 inducing agents, tBHQ (tert-butylhydroquinone) (15 M, 6 h) and SFN (sulforaphane) (10 M, 6 h), or the GSK-3 inhibitor SB216763 (20 M, 6 h). As shown in Fig. 1A , under these conditions both tBHQ and SFN modestly increased the level of Nrf2 protein, but had no effect on the level of -catenin, which was used as a control for inhibition of GSK-3. Interestingly, SB216763, which increased -catenin levels, also augmented the level of Nrf2 protein to a similar extent as when HEK293T cells were treated with either tBHQ or SFN alone. Moreover, co-treatment with SB216763 and either of the two inducing agents resulted in a further elevation in the amount of Nrf2 protein. Messenger RNA levels for Nrf2 did not differ significantly among treatments (Fig. 1B) ,
indicating that the increase in Nrf2 protein produced by tBHQ, SFN and SB216763 was not accompanied by up-regulation of the Nrf2 gene (Fig. 1B) .
The increase in Nrf2 protein correlated with higher transactivation activity as determined with an ARE-driven luciferase reporter construct, 3xARE-Luc, modulates Nrf2 levels through a Keap1 independent mechanism.
As an additional approach, we compared the levels of ectopically expressed V5-tagged wild-type Nrf2 with V5-tagged mutant Nrf2 ETGE that cannot be turned over in a Keap1-dependent fashion. As shown in Fig. 3A and 3C, SB216763 produced a time-dependent accumulation of both Nrf2-V5 and Nrf2
ETGE
-V5 (at 3 h and 6 h) as well as -catenin, which was used as an internal control for GSK-3 inhibition. To test whether GSK-3 and/or GSK-3 might be responsible for the increase in Nrf2, we knocked down each isoform using siRNA. HEK293T cells were first transfected with an expression vector for 3B and 3D ). These results complement the observations made with the GSK-3
inhibitor, and further indicate that Nrf2 stability is regulated by GSK-3.
Degradation of Nrf2 by the E3 Ubiquitin ligase SCF/-TrCP complex.
Using bioinformatics, we found that Nrf2 contains an evolutionarily conserved sequence that resembles the consensus motif for substrate recognition by - that lacks the first 9 N-terminal residues, including Ser9, and is insensitive to down-regulation by Akt phosphorylation.
The amount of His-Ub bound to Nrf2 was measured in a pull-down assay that employed nickel columns (Fig. 4F) . Protein recovered in the His-tagged fraction represented the poly-ubiquitinated transcription factor as no such protein was recovered in this fraction unless Nrf2 and His-Ub were co-expressed.
Interestingly, we could detect higher poly-ubiquitinated Nrf2 forms in cells overexpressing HA-GSK-3 -V5 protein (Fig. 7B ). These data show that the six Ser residues within or adjacent to the -TrCP destruction motif are necessary for the degradation of Nrf2 stimulated by GSK-3. -V5 was smaller than that of Nrf2 ETGE -V5. (Fig. 8A) . It is noteworthy that we still detected ubiquitination of Nrf2
Nrf2 lacking the 6S cluster in its Neh6 domain is insensitive to GSK-3-induced degradation.

The SCF/-TrCP complex does not promote ubiquitination of Nrf2
-V5, indicating the presence of other possible proteasome degradation motifs apart from those involving Keap1 and β-TrCP.
As expected, HA-GSK-3
9 promoted an increase in Nrf2 ETGE -V5 ubiquitination but, by contrast, it did not change the amount of ubiquitinated Nrf2
-V5.
Since substrate phosphorylation increases the affinity of -TrCP for its target proteins, we used a co-immunoprecipitation assay to examine whether the association of Nrf2 with -TrCP is dependent on phosphorylation (Fig. 8B ). was over-expressed we could detect higher amounts of Nrf2
GSK-3 activity was modulated in
bound to -TrCP but not higher amounts of Nrf2
-V5 bound to -TrCP.
These data correlate well with the results presented in Fig. 8A , and together they show that the lower ubiquitination of the 6S-mutant is compatible with an inability to interact with-TrCP.
As shown in Fig. 8D , the lack of association between β-TrCP and Nrf2
was accompanied by failure of SCF/-TrCP to regulate the transcription factor.
HEK293T cells were co-transfected with expression vectors encoding either Within its Neh6 domain, Nrf2 contains a conserved region that conforms to the consensus motif recognized by -TrCP. Thus Neh6 contains a typical DSG motif followed by an isoleucine and a phosphorylatable Ser residue. This
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DSGIS sequence is identical to that reported in the erythropoietin receptor (32) and the Yes-associated protein (53) . Interestingly, using a completely different approach, McMahon et al (30) reported a Keap1-independent degron in the same region of Nrf2 that -TrCP recognises, and postulated that it limited the stability of the transcription factor during redox stress, when the E3 ubiquitin ligase substrate adaptor activity of Keap1 is inhibited. The region in mouse Nrf2
that was identified as a redox-independent degron by McMahon and colleagues was narrowed down to residues 329-339, but this was not reported to be a -TrCP binding site, nor was it appreciated that it could be phosphorylated by GSK-3. We now propose that this redox-independent degron in the Neh6 domain also contains a cluster of Ser residues (in mouse Nrf2 these are Ser335, Ser338, Ser342, Ser347, Ser351 and Ser355) that are phosphorylated by GSK-3, probably in concert with other kinases.
GSK-3 provides a complex mode of regulation by protein phosphorylation, and presumably this applies to the phosphorylation of Nrf2. For the purpose of this discussion we will exemplify GSK-3 regulation of Nrf2 with the Ser/Thr protein kinase Akt. In cells exposed to growth and trophic factors, it is expected that GSK-3 will be inactivated by Akt-mediated phosphorylation at Ser9. On the other hand, during prolonged oxidative stress when Akt is down-regulated (for instance, by ceramide-activated phosphatase) (28, 41) , it is likely that GSK-3 activity will increase. Moreover, the mechanism of action is also unusual in that M CT99021. Thereafter, the fibroblasts that had been subjected to different treatments were harvested separately and each was lysed in 0.45 ml of buffer. 
